Abstract
Background
There are serious complications associated with hyaluronic acid (HA) facial injections, including vision impairment due to retinal artery ischemia. In this study, we put forth a clinically relevant model of retinal ischemia and reperfusion in rabbit. We used this to verify the efficacy of hyaluronidase intra-artery thrombolysis in the treatment of hyaluronic acid-induced retinal artery occlusion.
Methods
Retinal artery ischemia was induced by injecting HA into the ophthalmic artery (OA) of adult chinchilla rabbit, and reperfusion was achieved by intra-artery thrombolysis therapy with hyaluronidase following 60 min and 4 h of occlusion. Digital subtraction angiography (DSA) and fundus fluorescein angiography (FFA) were used to evaluate blood flow in the retina. Electroretinogram (ERG), hematoxylin and eosin staining and transmission electron microscope were used to evaluate the structure and function of the retina after ischemia and reperfusion following 60 min and 4 h of occlusion.
Results
DSA and FFA images confirmed occlusion of the ophthalmic and central retinal arteries, as well as reperfusion after hyaluronidase thrombolysis. ERG indicated retinal dysfunction following ischemia, and thrombolysis partially rescued its impairment following 4 h of occlusion. Hematoxylin and eosin staining and TUNEL staining revealed ischemia-induced histological damages in the retina at different time windows, and hyaluronidase thrombolysis partially mitigated these damages.
Conclusions
We report a method to establish a HA-induced retinal artery occlusion animal model. Hyaluronidase intra-artery thrombolysis was used to recanalize the embolized OA at different time points. Using our method, we achieved retinal reperfusion, and an improvement was observed in the visual function of rabbits after hyaluronidase thrombolysis following 4 h of occlusion. We believe that hyaluronidase intra-artery thrombolysis is an effective method to treat HA-induced retinal artery occlusion in clinic.
Level of Evidence II
This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.
Similar content being viewed by others
References
DeLorenzi C (2014) Complication of injectable fillers, part 2: vascular complications. Aesthet Surg J 34:584–600
DeLorenzi C (2017) New high dose pulsed hyaluronidase protocol for hyaluronic acid filler vascular adverse events. Aesthet Surg J 37:814–825
Page Paul S, Khattar Nicolas K, White Andrew C, Cambon Alexander C, Brock Guy N, Rai Shesh N, James Robert F (2018) Intra-arterial thrombolysis for acute central retinal artery occlusion: a systematic review and meta-analysis. Front Neurol. 9:76
Spertus AD, Slakter JS, Weissman SS, Henkind P (1984) Experimental carotid occlusion: funduscopic and fluorescein angiographic finding. Br J Ophthamol. 68:47–57
Ciulla TA, Pawlyk BS, Harris A, Oberoi A, Miller JW, Sandberg MA (2000) Endothelin-1-mediated retinal artery vasospasm and the rabbit electroretinogram. J Ocul Pharmacol Ther 16:393–398
Nanda SK, Hatchell DL, Tiedeman JS, Dutton JJ, Hatchell MC, McAdoo T (1987) A new method for vascular occlusion: photochemical initiation of thrombosis. Arch Ophthalmol 105:1121–1124
Jonas JB, Hayreh SS (1999) Optic disk morphology in experimental central retinal artery occlusion in rhesus monkeys. Am J Ophthalmol 127:523–530
Linner E (1961) Occlusion of the retinal veins in rabbits induced by light coagulation. Acta Ophthalmol (Copenh). 39:739–740
Moren H, Undren P, Gesslein B, Olivecrona GK, Andreasson S, Malmsjo M (2009) The porcine retinal vasculature accessed using an endovascular approach: a new experimental model for retinal ischemia. Invest Ophthalmol Vis Sci 50:5504–5510
Daniels AB, Froehler MT, Pierce JM, Nunnally AH, Wade Calcutt M, Bridges TM, LaNeveDC Williams PE, Boyd KL, Reyzer ML, Lindsley CW, Friedman DL, Richmond Ann (2018) Pharmacokinetics, tissue location, toxicity, and treatment efficacy in the first small animal (rabbit) model of intra-arterial chemotherapy for retinoblastoma. Invest Ophthalmol Vis Sci. 59:446–454
Marmor MF, Fulton AB, Holder GE, Miyake Y, Brigell M, Bach M (2009) International Society for Clinical Electrophysiology of Vision. ISCEV Standard for full-field clinical electroretinography (2008 update). Doc Ophthalmol 118:69–77
Zhang LiXia, Lai LinYing, Zhou GuiWen, Liang LiMing, Zhou YunChao, Bai XinYue, Dai Q, YouTao Yu, Tang WeiQiang, Chen MinLiang (2020) Evaluation of intraarterial thrombolysis in treatment of cosmetic facial filler-related ophthalmic artery occlusion. Plast Reconstr Surg 145(1):42e–50e
Xiao Xu, Zhou Guiwen, Qiang Fu, Zhang Lixia, Youtao Yu, Dong Ying, Liang Liming, Chen Minliang (2021) Efficacy of intra-arterial thrombolytic therapy for vision loss resulting from hyaluronic acid filler embolization. J Cosmet Dermatol. 20:3205–3212
Wang Jianfeng, Shen Haiyang, Liu Tao, Li Qian, Lyu Zhaoyang, Youtao Yu (2021) An efficacy and safety study of intra-arterial recanalization of occluded ophthalmic arteries in patients with monocular blindness caused by injection of hyaluronic acid in facial tissues. Aesthetic Plast Surg. 45(4):1573–1578
Chiang ChengAn, Zhou Shuang Bai, Chen ChuHsin, Ho Dave S, Zhang HuiZhong, Liu Kai (2016) Intravenous hyaluronidase with urokinase as treatment for rabbit retinal artery hyaluronic acid embolism. Plast Reconstr Surg. 138:1221–1229
Chen Jiabao, Ruan Jiyin, Wang Wei, Chen Zaizhong, Huang Qinying, Yang Yatong, Li Jinying (2021) Superselective arterial hyaluronidase thrombolysis is not an effective treatment for hyaluronic acid–induced retinal artery occlusion: study in a rabbit model. Plast reconstructive surg. 147(1):69–75
Chen Y-C, Hsiu-Mei Wu, Chen S-J, Lee H-J, Lirng J-F, Lin C-J, Chang F-C, Luo C-B, Guo W-Y (2018) Intra-arterial thrombolytic therapy is not a therapeutic option for filler-related central retinal artery occlusion. Facial Plast Surg 34(3):325–329
Kim YK, Jung C, Woo SJ, Park KH (2015) Cerebral angiographic findings of cosmetic facial filler-related ophthalmic and retinal artery occlusion. J Korean Med Sci 30(12):1847–1855
Funding
The fourth medical center of Chinese PLA General Hospital Innovation Science Fund (2024-4ZX-ZD-07).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Ethical Approval
All procedures were approved by the animal care and use committee of animal center in academy (IACUC-DWZX-2020-779).
Informed Consent
For this type of study, informed consent is not required.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Xu, X., Sun, X., Fu, Q. et al. Superselective Arterial Hyaluronidase Thrombolysis is an Effective Treatment for Hyaluronic Acid-Induced Retinal Artery Occlusion: Study in a Rabbit Model. Aesth Plast Surg (2024). https://doi.org/10.1007/s00266-024-03891-9
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s00266-024-03891-9